UNAIDS underscores how increased political will is needed to end AIDS by investing in sustainable responses that include evidence-based prevention and treatment, health systems integration, non-discriminatory laws, gender equality and strong community networks.
The Canadian Drug Policy Coalition provides insight about value-based and implementation-focused priorities that centre drug user leadership in the development and expansion of safe supply models in Canada.
Olding et al. highlight the many functions that overdose prevention sites play in people's lives and how adaptations to high demand can have unintended impacts on these, underscoring the importance of complementary structural changes and service innovations.
IDPC calls on the UN system and Member States to initiate a process to evaluate the human rights impacts of the global drug control regime, and to propose concrete steps for its reform and modernisation.
The Scottish government proposes reforms to the UK's drug laws to support a public health approach that facilitates harm reduction measures, including decriminalisation and debate on regulated drug markets.
Van Selm et al. highlight the considerable lack of data regarding migrants who use drugs and their access to drug dependency services, with 15 recommendations designed to improve data collection and service accessibility and availability,
Scher et al. highlight, based on interviews with people who use drugs, how the criminalisation of drugs shapes experiences of structural, social and self stigma.
Rigoni et al. summarise expert and public opinions on the regulation of MDMA collected in relation to a pop-up installation (the 'XTC store') in Utrecht (the Netherlands) highlighting support for a strictly regulated market for MDMA products.
PRI and TIJ provide an overview and highlight how the criminalisation of drugs remains a key contributing factor to the rising global prison population and prison overcrowding.
Mainline review the current harm reduction programmes in Nepal from the perspective of women who inject drugs, and formulate recommendations to improve service delivery.
The EMCDDA shed light on emerging trends, challenges, and policy implications surrounding drug use in Europe up until the end of 2022, revealing high availability of substances and a greater need for harm reduction services.
